title: Inflation in the number of eligibility criteria for industry-sponsored phase II cancer clinical trial: illustration over a 20-year period.
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Clisant
authors.forename: Aurélie
authors.initials: A
authors.lastname: Clermont
authors.forename: Antoine
authors.initials: A
authors.lastname: Adenis
authors.forename: Nicolas
authors.initials: N
authors.lastname: Penel
mesh_terms: D017322:Clinical Trials, Phase II as Topic / Q000379:methods*; D015195:Drug Design; D006801:Humans; D018579:Patient Selection; D013997:Time Factors